We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients receiving mepolizumab vs. placebo had a ...

Membrane lipids may have helped shape the evolution of proteins in the respiratory complexes of mitochondria, a team of cell biologists at the CSIR-Centre for Cellular and Molecular Biology in ...

Findings suggest that mitochondrial fragmentation can bypass defects in mitophagy, the process by which cells remove damaged mitochondria, to sustain skeletal muscle quality control in patients ...

Ohtuvayre is the first novel inhaled mechanism for the maintenance treatment of COPD in more than 20 years. The ENHANCE posters highlight subgroup analyses of patients when used as monotherapy ...

Anna University Hospital. AZ’s triple-combination therapy is already approved under the brand names Breztri Aerosphere and Trixeo Aerosphere to treat chronic obstructive pulmonary disease (COPD), a ...

Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine, which has been tipped as a future blockbuster. The first-in-class dual ...

As Healio previously reported, the FDA approved Breztri Aerosphere for maintenance treatment of patients with COPD in 2020. “Breztri forms the backbone of our inhaled medicine portfolio in COPD, ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.

Chronic obstructive pulmonary disease (COPD) is also a leading cause of death, but unlike the others, has remained under-prioritized for decades. In 2023, COPD research received less than two ...

I ncreased perceived stress may cause worsened respiratory symptoms and decreased quality of life in people with chronic obstructive pulmonary disease (COPD), according to a new study. The study ...

Chronic obstructive pulmonary disease (COPD) is increasing in prevalence, affecting over 14 million individuals in the US alone. Several features of COPD (dyspnea, air hunger, functional decline ...